AAP
RGEN icon

Arax Advisory Partners’s Repligen RGEN Stock Holding History

Arax Advisory Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-122
Closed -$20K – 4236
2025
Q4 		$20K Buy
122
+41
+51% +$6.42K ﹤0.01% 2112
2025
Q3 		$10.8K Buy
81
+29
+56% +$3.52K ﹤0.01% 2559
2025
Q2 		$6.47K Buy
+52
New +$6.62K ﹤0.01% 2143
2022
Q2 		– Sell
-18
Closed -$3K – 1221
2022
Q1 		$3K Hold
18
– – ﹤0.01% 895
2021
Q4 		$5K Hold
18
– – ﹤0.01% 775
2021
Q3 		$5K Buy
+18
New +$4.62K ﹤0.01% 761

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Arax Advisory Partners's RGEN Position: Q1 2026 in Review

Arax Advisory Partners sold out of Repligen (RGEN) in Q1 2026, closing a stake of 122 shares — an estimated $20K sold.

Arax Advisory Partners first reported a position in RGEN in Q3 2021 and held it in 6 quarters. The position peaked at $20K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Arax Advisory Partners reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 122 Repligen shares in Q1 2026, an estimated $20K.
  • Arax Advisory Partners first reported a position in Repligen in Q3 2021 and held it in 6 quarters.
  • Arax Advisory Partners's Repligen position peaked at $20K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.